FHIR IG analytics| Package | de.medizininformatikinitiative.kerndatensatz.seltene |
| Resource Type | ValueSet |
| Id | ValueSet-mii-vs-seltene-nbs-ratio-dbs.json |
| FHIR Version | R4 |
| Source | https://medizininformatik-initiative.github.io/kerndatensatzmodul-seltene-erkrankungen/2027.0.0-ballot/ValueSet-mii-vs-seltene-nbs-ratio-dbs.html |
| URL | https://www.medizininformatik-initiative.de/fhir/ext/modul-seltene/ValueSet/mii-vs-seltene-nbs-ratio-dbs |
| Version | 2027.0.0-ballot |
| Status | active |
| Date | 2026-09-14T21:59:44+00:00 |
| Name | MII_VS_Seltene_NBS_Ratio_DBS |
| Title | MII VS Seltene Erkrankungen NBS Quotienten (Trockenblut) |
| Realm | de |
| Description | Diagnostische Quotienten aus Trockenblut-Analyten. Im Neugeborenenscreening tragen die Verhältnisse (z. B. C3/C2, Phe/Tyr) einen großen Teil der diagnostischen Trennschärfe, weil sie von der Probenqualität weniger abhängen als Einzelwerte. |
No resources found
| CodeSystem | ||
| kl.dk.fhir.children#2.1.0 | loinc.org | Logical Observation Identifiers, Names and Codes (LOINC) |
Note: links and images are rebased to the (stated) source
English
Generated Narrative: ValueSet mii-vs-seltene-nbs-ratio-dbs
Profiles: CRMI Shareable ValueSet, CRMI Publishable ValueSet
http://loinc.org version Not Stated (use latest from terminology server)| Code | Display |
| 53171-5 | 3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in DBS |
| 53172-3 | 3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS |
| 53201-0 | 3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 75214-7 | Arginine/Ornithine [Molar ratio] in DBS |
| 53398-4 | Arginine/Phenylalanine [Molar ratio] in DBS |
| 53200-2 | Argininosuccinate/Arginine [Molar ratio] in DBS |
| 45192-2 | Carnitine esters/Carnitine.free (C0) [Molar ratio] in DBS |
| 54092-2 | Citrulline/Arginine [Molar ratio] in DBS |
| 53157-4 | Citrulline/Phenylalanine [Molar ratio] in DBS |
| 53399-2 | Citrulline/Tyrosine [Molar ratio] in DBS |
| 104196-1 | Creatine/Creatinine [Molar ratio] in DBS |
| 53233-3 | Carnitine free (C0)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 53234-1 | Carnitine free (C0)/Stearoylcarnitine (C18) [Molar ratio] in DBS |
| 88016-1 | Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 75225-3 | Glutarylcarnitine (C5-DC)/Carnitine (C0) [Molar ratio] in DBS |
| 75216-2 | Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC) [Molar ratio] in DBS |
| 75267-5 | Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 88017-9 | Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3) [Molar ratio] in DBS |
| 107506-8 | Guanidinoacetate/Creatine [Molar ratio] in DBS |
| 104195-3 | Guanidinoacetate/Creatinine [Molar ratio] in DBS |
| 75268-3 | Leucine/Phenylalanine [Molar ratio] in DBS |
| 75212-1 | Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
| 53181-4 | Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS |
| 80154-8 | Monolysocardiolipin/Cardiolipin [Molar ratio] in DBS |
| 53176-4 | Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 53177-2 | Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
| 88014-6 | Octanoylcarnitine (C8)/Carnitine.free (C0) [Molar ratio] in DBS |
| 75215-4 | Ornithine/Citrulline [Molar ratio] in DBS |
| 88015-3 | Palmitoylcarnitine (C16)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 88024-5 | Palmitoylcarnitine (C16)/Carnitine.free (C0) [Molar ratio] in DBS |
| 74300-5 | Phenylalanine/Tyrosine [Molar ratio] in DBS --post therapeutic diet |
| 35572-7 | Phenylalanine/Tyrosine [Molar ratio] in DBS |
| 53392-7 | Proline/Phenylalanine [Molar ratio] in DBS |
| 53163-2 | Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 53162-4 | Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in DBS |
| 53164-0 | Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 53161-6 | Propionylcarnitine (C3)/Methionine [Molar ratio] in DBS |
| 53156-6 | Methionine/Phenylalanine [Molar ratio] in DBS |
| 53400-8 | Stearoylcarnitine (C18)/Propionylcarnitine (C3) [Molar ratio] in DBS |
| 53193-9 | Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 53194-7 | Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in DBS |
| 88025-2 | Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0) [Molar ratio] in DBS |
| 53195-4 | Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 70159-9 | Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in DBS |
| 74481-3 | Tyrosine/Phenylalanine [Molar ratio] in DBS |
| 74299-9 | Tyrosine/Phenylalanine [Molar ratio] in DBS --post therapeutic diet |
| 53151-7 | Valine/Phenylalanine [Molar ratio] in DBS |
German
Generated Narrative: ValueSet mii-vs-seltene-nbs-ratio-dbs
Profiles: CRMI Shareable ValueSet, CRMI Publishable ValueSet
http://loinc.org version Not Stated (use latest from terminology server)| Code | Display |
| 53171-5 | 3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in DBS |
| 53172-3 | 3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS |
| 53201-0 | 3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 75214-7 | Arginine/Ornithine [Molar ratio] in DBS |
| 53398-4 | Arginine/Phenylalanine [Molar ratio] in DBS |
| 53200-2 | Argininosuccinate/Arginine [Molar ratio] in DBS |
| 45192-2 | Carnitine esters/Carnitine.free (C0) [Molar ratio] in DBS |
| 54092-2 | Citrulline/Arginine [Molar ratio] in DBS |
| 53157-4 | Citrulline/Phenylalanine [Molar ratio] in DBS |
| 53399-2 | Citrulline/Tyrosine [Molar ratio] in DBS |
| 104196-1 | Creatine/Creatinine [Molar ratio] in DBS |
| 53233-3 | Carnitine free (C0)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 53234-1 | Carnitine free (C0)/Stearoylcarnitine (C18) [Molar ratio] in DBS |
| 88016-1 | Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 75225-3 | Glutarylcarnitine (C5-DC)/Carnitine (C0) [Molar ratio] in DBS |
| 75216-2 | Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC) [Molar ratio] in DBS |
| 75267-5 | Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 88017-9 | Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3) [Molar ratio] in DBS |
| 107506-8 | Guanidinoacetate/Creatine [Molar ratio] in DBS |
| 104195-3 | Guanidinoacetate/Creatinine [Molar ratio] in DBS |
| 75268-3 | Leucine/Phenylalanine [Molar ratio] in DBS |
| 75212-1 | Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
| 53181-4 | Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS |
| 80154-8 | Monolysocardiolipin/Cardiolipin [Molar ratio] in DBS |
| 53176-4 | Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 53177-2 | Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
| 88014-6 | Octanoylcarnitine (C8)/Carnitine.free (C0) [Molar ratio] in DBS |
| 75215-4 | Ornithine/Citrulline [Molar ratio] in DBS |
| 88015-3 | Palmitoylcarnitine (C16)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 88024-5 | Palmitoylcarnitine (C16)/Carnitine.free (C0) [Molar ratio] in DBS |
| 74300-5 | Phenylalanine/Tyrosine [Molar ratio] in DBS --post therapeutic diet |
| 35572-7 | Phenylalanine/Tyrosine [Molar ratio] in DBS |
| 53392-7 | Proline/Phenylalanine [Molar ratio] in DBS |
| 53163-2 | Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 53162-4 | Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in DBS |
| 53164-0 | Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 53161-6 | Propionylcarnitine (C3)/Methionine [Molar ratio] in DBS |
| 53156-6 | Methionine/Phenylalanine [Molar ratio] in DBS |
| 53400-8 | Stearoylcarnitine (C18)/Propionylcarnitine (C3) [Molar ratio] in DBS |
| 53193-9 | Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in DBS |
| 53194-7 | Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in DBS |
| 88025-2 | Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0) [Molar ratio] in DBS |
| 53195-4 | Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
| 70159-9 | Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in DBS |
| 74481-3 | Tyrosine/Phenylalanine [Molar ratio] in DBS |
| 74299-9 | Tyrosine/Phenylalanine [Molar ratio] in DBS --post therapeutic diet |
| 53151-7 | Valine/Phenylalanine [Molar ratio] in DBS |
{
"resourceType": "ValueSet",
"id": "mii-vs-seltene-nbs-ratio-dbs",
"meta": {
"profile": [
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablevalueset",
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablevalueset"
]
},
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability",
"valueCode": "shareable"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability",
"valueCode": "publishable"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability",
"valueCode": "computable"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-versionPolicy",
"valueCodeableConcept": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/artifact-version-policy-codes",
"code": "package",
"display": "Package"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-approvalDate",
"valueDate": "2026-09-02"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-topic",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C4873"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-author",
"valueContactDetail": {
"telecom": [
{
"system": "email",
"value": "thomas.debertshaeuser@charite.de"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-editor",
"valueContactDetail": {
"name": "Taskforce Core Data Set"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-reviewer",
"valueContactDetail": {
"name": "Interoperability Working Group",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/en/collaboration/interoperability-working-group"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-reviewer",
"valueContactDetail": {
"name": "National Steering Committee",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/en/collaboration/national-steering-committee"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-endorser",
"valueContactDetail": {
"name": "Interoperability Working Group",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/en/collaboration/interoperability-working-group"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-endorser",
"valueContactDetail": {
"name": "National Steering Committee",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/en/collaboration/national-steering-committee"
}
]
}
}
],
"url": "https://www.medizininformatik-initiative.de/fhir/ext/modul-seltene/ValueSet/mii-vs-seltene-nbs-ratio-dbs",
"version": "2027.0.0-ballot",
"name": "MII_VS_Seltene_NBS_Ratio_DBS",
"title": "MII VS Seltene Erkrankungen NBS Quotienten (Trockenblut)",
"status": "active",
"experimental": false,
"date": "2026-09-14T21:59:44+00:00",
"publisher": "Medizininformatik Initiative",
"_publisher": {
"extension": [
{
"extension": [
{
"url": "lang",
"valueCode": "de"
},
{
"url": "content",
"valueString": "Medizininformatik Initiative"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/translation"
}
]
},
"contact": [
{
"name": "Medizininformatik Initiative",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/"
}
]
}
],
"description": "Diagnostische Quotienten aus Trockenblut-Analyten. Im Neugeborenenscreening tragen die Verhältnisse (z. B. C3/C2, Phe/Tyr) einen großen Teil der diagnostischen Trennschärfe, weil sie von der Probenqualität weniger abhängen als Einzelwerte.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "DE",
"display": "Germany"
}
]
}
],
"compose": {
"include": [
{
"system": "http://loinc.org",
"concept": [
{
"code": "53171-5",
"display": "3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in DBS"
},
{
"code": "53172-3",
"display": "3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS"
},
{
"code": "53201-0",
"display": "3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS"
},
{
"code": "75214-7",
"display": "Arginine/Ornithine [Molar ratio] in DBS"
},
{
"code": "53398-4",
"display": "Arginine/Phenylalanine [Molar ratio] in DBS"
},
{
"code": "53200-2",
"display": "Argininosuccinate/Arginine [Molar ratio] in DBS"
},
{
"code": "45192-2",
"display": "Carnitine esters/Carnitine.free (C0) [Molar ratio] in DBS"
},
{
"code": "54092-2",
"display": "Citrulline/Arginine [Molar ratio] in DBS"
},
{
"code": "53157-4",
"display": "Citrulline/Phenylalanine [Molar ratio] in DBS"
},
{
"code": "53399-2",
"display": "Citrulline/Tyrosine [Molar ratio] in DBS"
},
{
"code": "104196-1",
"display": "Creatine/Creatinine [Molar ratio] in DBS"
},
{
"code": "53233-3",
"display": "Carnitine free (C0)/Palmitoylcarnitine (C16) [Molar ratio] in DBS"
},
{
"code": "53234-1",
"display": "Carnitine free (C0)/Stearoylcarnitine (C18) [Molar ratio] in DBS"
},
{
"code": "88016-1",
"display": "Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2) [Molar ratio] in DBS"
},
{
"code": "75225-3",
"display": "Glutarylcarnitine (C5-DC)/Carnitine (C0) [Molar ratio] in DBS"
},
{
"code": "75216-2",
"display": "Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC) [Molar ratio] in DBS"
},
{
"code": "75267-5",
"display": "Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in DBS"
},
{
"code": "88017-9",
"display": "Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3) [Molar ratio] in DBS"
},
{
"code": "107506-8",
"display": "Guanidinoacetate/Creatine [Molar ratio] in DBS"
},
{
"code": "104195-3",
"display": "Guanidinoacetate/Creatinine [Molar ratio] in DBS"
},
{
"code": "75268-3",
"display": "Leucine/Phenylalanine [Molar ratio] in DBS"
},
{
"code": "75212-1",
"display": "Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS"
},
{
"code": "53181-4",
"display": "Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS"
},
{
"code": "80154-8",
"display": "Monolysocardiolipin/Cardiolipin [Molar ratio] in DBS"
},
{
"code": "53176-4",
"display": "Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in DBS"
},
{
"code": "53177-2",
"display": "Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in DBS"
},
{
"code": "88014-6",
"display": "Octanoylcarnitine (C8)/Carnitine.free (C0) [Molar ratio] in DBS"
},
{
"code": "75215-4",
"display": "Ornithine/Citrulline [Molar ratio] in DBS"
},
{
"code": "88015-3",
"display": "Palmitoylcarnitine (C16)/Acetylcarnitine (C2) [Molar ratio] in DBS"
},
{
"code": "88024-5",
"display": "Palmitoylcarnitine (C16)/Carnitine.free (C0) [Molar ratio] in DBS"
},
{
"code": "74300-5",
"display": "Phenylalanine/Tyrosine [Molar ratio] in DBS --post therapeutic diet"
},
{
"code": "35572-7",
"display": "Phenylalanine/Tyrosine [Molar ratio] in DBS"
},
{
"code": "53392-7",
"display": "Proline/Phenylalanine [Molar ratio] in DBS"
},
{
"code": "53163-2",
"display": "Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in DBS"
},
{
"code": "53162-4",
"display": "Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in DBS"
},
{
"code": "53164-0",
"display": "Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in DBS"
},
{
"code": "53161-6",
"display": "Propionylcarnitine (C3)/Methionine [Molar ratio] in DBS"
},
{
"code": "53156-6",
"display": "Methionine/Phenylalanine [Molar ratio] in DBS"
},
{
"code": "53400-8",
"display": "Stearoylcarnitine (C18)/Propionylcarnitine (C3) [Molar ratio] in DBS"
},
{
"code": "53193-9",
"display": "Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in DBS"
},
{
"code": "53194-7",
"display": "Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in DBS"
},
{
"code": "88025-2",
"display": "Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0) [Molar ratio] in DBS"
},
{
"code": "53195-4",
"display": "Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in DBS"
},
{
"code": "70159-9",
"display": "Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in DBS"
},
{
"code": "74481-3",
"display": "Tyrosine/Phenylalanine [Molar ratio] in DBS"
},
{
"code": "74299-9",
"display": "Tyrosine/Phenylalanine [Molar ratio] in DBS --post therapeutic diet"
},
{
"code": "53151-7",
"display": "Valine/Phenylalanine [Molar ratio] in DBS"
}
]
}
]
}
}